Related references
Note: Only part of the references are listed.Biomarkers and personalised medicine in rheumatoid arthritis: a proposal for interactions between academia, industry and regulatory bodies
P. Miossec et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Biomarkers for prediction of TNFα blockers response in rheumatoid arthritis
Hubert Marotte et al.
JOINT BONE SPINE (2010)
Predictors for Remission in Rheumatoid Arthritis Patients: A Systematic Review
Wanruchada Katchamart et al.
ARTHRITIS CARE & RESEARCH (2010)
Predictors of response to anti-TNF therapy according to ACR and EULAR criteria in patients with established RA:: results from the South Swedish Arthritis Treatment Group Register
L. E. Kristensen et al.
RHEUMATOLOGY (2008)
Clinical remission and/or minimal disease activity in patients receiving adalimumab treatment in a multinational, open-label, twelve-week study
Gerd R. Burmester et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2008)
Disease remission and sustained halting of radiographic progression with combination etanercept and methotrexate in patients with rheumatoid arthritis
D. van der Heijde et al.
ARTHRITIS AND RHEUMATISM (2007)
Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial)
S. M. M. Verstappen et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Sex: a major predictor of remission in early rheumatoid arthritis?
K. Forslind et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Predictors of response to anti-TNF-α therapy among patients with rheumatoid arthritis:: results from the British Society for Rheumatology Biologics Register
K. L. Hyrich et al.
RHEUMATOLOGY (2006)
British society for rheumatology and british health professionals in rheumatology guideline for the management of rheumatoid arthritis (the first two years)
R. Luqmani et al.
RHEUMATOLOGY (2006)
Comparison of the response to infliximab or etanercept monotherapy with the response to cotherapy with methotrexate or another disease-modifying antirheumatic drug in patients with rheumatoid arthritis - Results from the British Society for Rheumatology Biologics Register
Kimme L. Hyrich et al.
ARTHRITIS AND RHEUMATISM (2006)
Effectiveness of systematic monitoring of rheumatoid arthritis disease activity in daily practice: a multicentre, cluster randomised controlled trial
J Fransen et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
What are the goals and principles of management in the early treatment of rheumatoid arthritis?
VP Bykerk et al.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2005)
A good response to early DMARD treatment of patients with rheumatoid arthritis in the first year predicts remission during follow up
SMM Verstappen et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Delay to institution of therapy and induction of remission using single-drug or combination-disease-modifying antirheumatic drug therapy in early rheumatoid arthritis
T Möttönen et al.
ARTHRITIS AND RHEUMATISM (2002)
Influence of HLA polymorphism on persistent remission in rheumatoid arthritis
ETH Molenaar et al.
ANNALS OF THE RHEUMATIC DISEASES (2002)
Share Paper
